Market Highlights
Balantidiasis is a disease caused by the bacterium Balantidium coli which mainly affects the large intestine. The disease spreads through fecal-oral route due to the contamination of food and water by the feces of pig or human. Improper sanitary conditions and unsafe drinking water are important aspects for the spread of the diseases.
The market is driven by the increasing prevalence of communicable diseases in rural areas for developing countries. In addition, increasing research and development activities, technological advancements to identify the causes and risk factors for transmission of infectious agents and developing new solutions to minimize patient exposure is another major driver, fuelling the global market growth.
The global balantidiasis market share is expected to grow at a CAGR of 7.20% during the forecast period.
Avail the in-depth table of content (TOC) & market synopsis on “Balantidiasis market research report–Global forecast till 2030.”
Regional Analysis
The market is found to be steady in Americas. Emphasis on healthy lifestyle and prevention of communicable diseases also influence the growth of the market. The prevalence of the disease is found to the higher rural South America than North American countries.
In Europe, the prevalence of balantidiasis is found to be low which is attributed to stringent regulations governing the manufacturing of food products and low prevalence of gastrointestinal diseases.
In Asia Pacific, the prevalence of balantidiasis is found increasing steadily as a result of increasing prevalence of colitis, chronic diarrhea, and, deep intestinal ulcerations, poor healthcare system, and availability of treatment options for various gastrointestinal diseases.
In the Middle East & Africa, gastrointestinal diseases are a major cause of disability. The infection is mainly acquired due to ingestion of food and water contaminated by cysts.
Segmentation
The global balantidiasis market size is segmented on the basis of diagnosis, treatment, and end user.
On the basis of diagnosis, the market is segmented into stool examination, sigmoidoscopy, biopsy, and others.
On the basis of treatment, the market is segmented into antibiotics, appendectomy, and others. Antibiotics segment is further divided into tetracycline, metronidazole, and others.
On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, and others.
Major Players in the Market:
Some of the key players mentioned in the Balantidiasis Market trends report are Pfizer (U.S.), Abbott (U.S.), GlaxoSmithKline plc. (U.K), BD (U.S.), Sandoz International GmbH (Germany), Amneal Pharmaceuticals LLC. (U.S.), Akorn, Inc. (U.S.), and PharmaDerm, A division of Fougera Pharmaceuticals Inc. (U.S.).
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
